Navigation Links
Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes
Date:5/22/2009

FRAZER, Pa., May 22 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that the underwriters of its previously announced offering of $435 million in aggregate principal amount of 2.50% convertible senior subordinated notes due 2014 have exercised in full their over-allotment option to purchase $65 million of additional notes, bringing the total amount of the notes to be issued to $500 million. Completion of the notes offering, including the additional notes, is subject to customary closing conditions, and is expected to close on May 27, 2009.

Subject to certain conditions, the additional notes are convertible prior to maturity into cash and shares, if any, of the company's common stock at an initial conversion price of $69.00 per share of common stock (equivalent to a conversion rate of approximately 14.4928 shares per $1,000 principal amount of notes). As previously disclosed, Cephalon will use a portion of the net proceeds of the offering to pay the net cost of the convertible note hedge and warrant transactions that Cephalon entered into in connection with offering of the notes. As the underwriters have exercised their option to purchase additional notes, Cephalon expects to increase the number of shares of common stock underlying the convertible note hedge and warrant transactions on a pro rata basis, and Cephalon expects to use a portion of the net proceeds from the sale of the additional notes to pay the net cost of such increase. Holders of the notes will not have any rights with respect to the convertible note hedge or the warrant transaction. The notes will be subordinate to existing and future senior indebtedness, equal to existing and future senior subordinated indebtedness and senior in right of payment to existing and future subordinated indebtedness of Cephalon.

This announcement is neither an
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... Los Angeles, CA (PRWEB) July 12, 2014 ... a buyer power score of 4.1 out of ... the market that have been underpinning buyer negotiation ... to IBISWorld procurement analyst Anna Son, “during the ... along with rising costs associated with new product ...
(Date:7/12/2014)... Ladies, it doesn't matter what your budget is, the ... for an affordable gown can visit Discount-Dress.com (a ... their dream items. Recently, the company has announced its new ... with that, it is also providing great discounts for these ... deadline of this promotion is July 29, 2014. , ...
(Date:7/11/2014)... The American Association of Poison Control ... are commending Senator Bill Nelson (D-FL) for his introduction ... on July 10, 2014. Along with fellow Senate co-sponsors, ... (CPSC) to enact rules requiring safer, child-resistant packaging for ... Senate co-sponsors of the bill include: Sen. Richard Blumenthal ...
(Date:7/11/2014)... 11, 2014 As transvaginal mesh ... Johnson & Johnson’s Ethicon Inc. unit continue to ... that the Texas Attorney General’s Office has acknowledged ... surgical mesh products used to treat pelvic organ ... report from kens5.com, the probe began nearly two ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- People with the lowest ... called peripheral artery disease (PAD), a new study suggests. ... blood to the limbs, most often the legs. The condition ... of the arteries throughout the body. People with PAD have ... analyzed data from nearly 6,800 people with PAD who took ...
Breaking Medicine News(10 mins):Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Poor More Prone to Leg Circulation Trouble 2
... of cancer and the economy are converging in the Texas ... on funding for the Cancer Prevention and Research Institute of ... authorizing $3 billion over 10 years in general obligation bonds ... come for the Legislature to fulfill the wishes of Texas ...
... of $0.51(1), Excluding $0.02 of Expenses Related to Tepnel ... a Constant Currency(2) Basis ---- Company Generates Total Revenues ... Million --SAN DIEGO, April 30 Gen-Probe Incorporated (Nasdaq: ... the first quarter of 2009, including non-GAAP earnings per ...
... Gives Schools a Free ,Simple as ABC, Always Be ... Calif., April 30 Woodward Laboratories, a leading antimicrobial ... alcohol-free instant hand sanitizer that exceeds the Food and ... washes, reports a tremendous spike in sales in the ...
... group of arthritidies that share clinical features ... at sites where tendons attach to bone. ... inflammatory bowel-disease-related arthritis, reactive arthritis (ReA) and ... Chlamydia pneumoniae (which are often asymptomatic) frequently ...
... April 30 The Missouri House today amended ... funds to go to grants for maternity homes and pregnancy ... being considered by the Missouri Senate. , , ... homes and pregnancy resource centers are essential to helping pregnant ...
... Contract Manufacturing Organizations Now Available on goBalto.comSAN FRANCISCO, ... partnering site for the pharmaceutical development and drug ... LLC is making its proprietary list ... and Contract Manufacturing Organizations (CMOs) available on ...
Cached Medicine News:Health News:Texas Cancer Organizations Urge State Legislature to Fully Fund the Cancer Prevention and Research Institute of Texas 2Health News:Gen-Probe Reports Financial Results for First Quarter 2009 2Health News:Gen-Probe Reports Financial Results for First Quarter 2009 3Health News:Gen-Probe Reports Financial Results for First Quarter 2009 4Health News:Gen-Probe Reports Financial Results for First Quarter 2009 5Health News:Gen-Probe Reports Financial Results for First Quarter 2009 6Health News:Gen-Probe Reports Financial Results for First Quarter 2009 7Health News:Gen-Probe Reports Financial Results for First Quarter 2009 8Health News:Gen-Probe Reports Financial Results for First Quarter 2009 9Health News:Gen-Probe Reports Financial Results for First Quarter 2009 10Health News:Gen-Probe Reports Financial Results for First Quarter 2009 11Health News:Gen-Probe Reports Financial Results for First Quarter 2009 12Health News:Gen-Probe Reports Financial Results for First Quarter 2009 13Health News:Gen-Probe Reports Financial Results for First Quarter 2009 14Health News:Gen-Probe Reports Financial Results for First Quarter 2009 15Health News:Gen-Probe Reports Financial Results for First Quarter 2009 16Health News:Gen-Probe Reports Financial Results for First Quarter 2009 17Health News:Gen-Probe Reports Financial Results for First Quarter 2009 18Health News:Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic 2Health News:Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic 3Health News:Chlamydia may play role in a type of arthritis 2Health News:goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations 2Health News:goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations 3
(Date:7/11/2014)... 11, 2014 According to ... Composition of Material, Application (Healthcare, Homeland security, Industrial ... (Personal Instrument, Hand-Held Instruments, Fixed, and Installed Instruments) ... 2013 - 2020", published by MarketsandMarkets, the Scintillator Market is ... from 2014 to 2020, and reach $479.16 Million ...
(Date:7/11/2014)... New York , July 11, 2014 ... by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic ... Size, Share, Growth, Trends and Forecast, 2013-2019" the global ... in 2012 and is expected to grow at a ... an estimated value of USD 36.9 billion in 2019. ...
(Date:7/10/2014)...  Major advances in radiation therapy and radiosurgery ... in a three-day Oncology Summit taking place in ...  Renowned national and international cancer experts from seven countries ... knowledge on modern technologies making treatment for cancer ... The Summit will address a wide spectrum ...
Breaking Medicine Technology:Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... /PRNewswire-Asia/ -- To thank customers for their continuous support ... , heart beat watches, blood pressure monitors and so ... to offer these products with discounts ranging ... and offer more suitable products to customers, Wuzhou Changlian ...
... Calif., and CAMBRIDGE, Mass., June 8, 2011 ... discovery and development of innovative medicines targeting microRNAs, and ... leading RNAi therapeutics company, today announced the publication ... in mice about the antagonism of microRNA-103 and microRNA-107 ...
Cached Medicine Technology:Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 2Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 3Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 4Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 5Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 6Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes 7
... The Natural Knee design includes ... proprietary CSTi porous coating option ... patients, a unique bone preserving ... trochlear groove to maximize range ...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... Duracon tibial inserts have radiused A/P ... 4-axis machining, maximizing conformity of the ... of the femoral component. The resulting ... Duracon system, and accommodates the knee's ...
Medicine Products: